Surrey Heartlands

Joint Formulary & PAD

Tryptophan - Treatment resistant depression

You are here : Home > Formulary Search > Tryptophan - Treatment resistant depression

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

See narrative
Formulations :
  • Capsules
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
NFD2
Restrictions / Comments :
Important

This drug has not yet been assessed for formulary status. Contact your pharmacy team for advice on making an application to APC.

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Tryptophan
Indication :
Treatment resistant depression
Group Name :
Keywords :
L-tryptophan
Brand Names Include :
Optimax
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Tryptophan is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Treatment resistant depression.

Committee Recommendations (1)

28 Feb 24 - Not Set

This drug has not yet been assessed for formulary status and is not currently on the APC work-plan.

This drug has not yet been evaluated by the Surrey Heartlands ICS Area Prescribing Committee (APC).  As such, advice regarding safety, effectiveness (including cost-effectiveness) and its place in therapy is yet to be determined.

Before prescribing this drug it is recommended that clinicians contact their Medicines Optimisation team to discuss possible alternatives/options.

The APC will consider recommending the prescribing of this treatment upon submission of a formal request with its associated evidence. Clinicians can contact syheartlandsicb.APC@nhs.net  if they wish to make a submission.